Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An outcomes study of an occupational medicine intervention program for the reduction of musculoskeletal disorders and cumulative trauma disorders in the workplace.
Journal of occupational and environmental medicine·1999
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Journal of affective disorders·1999
Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
Psychopharmacology bulletin·1997
A pharmacoeconomic model to evaluate antibiotic costs.
Pharmacotherapy·1994
Fluoxetine impairs clearance of alprazolam but not of clonazepam.
Clinical pharmacology and therapeutics·1992
"Peripheral-type" binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5-4864.
Journal of neurochemistry·1985
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026